IP receptor (prostacyclin pathway) drugs for Idiopathic Pulmonary Fibrosis
2 tracked IP receptor (prostacyclin pathway) drugs in the Idiopathic Pulmonary Fibrosis race. The class explanation lives on the IP receptor (prostacyclin pathway) page; the full indication pipeline across every mechanism is on the Idiopathic Pulmonary Fibrosis page.
1 Phase 31 preclinical / unstaged